NCT05075811View on ClinicalTrials.gov

Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease

PHASE1/PHASE2UnknownINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

November 15, 2024

Study Completion Date

November 15, 2024

Conditions

Pouch, IlealFistula

Interventions

DRUG

Ossium vBM-MSC

Vertebral bone marrow derived mesenchymal stem cells

OTHER

Placebo

Normal Saline

Trial Locations (1)

44195

RECRUITING

Cleveland Clinic, Cleveland

Sponsors

Collaborators (1)

Ossium Health, Inc.

All Listed Sponsors

collaborator

Ossium Health, Inc.

INDUSTRY

lead

Amy Lightner

OTHER

NCT05075811 - Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease | Biotech Hunter | Biotech Hunter